Efficacy and safety of canagliflozin in older subjects with type 2 diabetes mellitus

被引：0
|
作者：
Sinclair, A. [1 ]
Bode, B. [2 ]
Harris, S. [3 ]
Vijapurkar, U. [4 ]
Gassmann-Mayer, C. [5 ]
Fung, A. [4 ]
Shaw, W. [4 ]
Usiskin, K. [4 ]
Desai, M. [4 ]
Meininger, G. [4 ]
机构：
[1] Luton & Dunstable Univ Hosp, Luton, Beds, England
[2] Atlanta Diabet Associates, Atlanta, GA USA
[3] Univ Western Ontario, London, ON, Canada
[4] Janssen Res & Dev LLC, Raritan, NJ USA
[5] Janssen Res & Dev LLC, Titusville, FL USA
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
955
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
    Stenlof, K.
    Cefalu, W. T.
    Kim, K. -A.
    Alba, M.
    Usiskin, K.
    Tong, C.
    Canovatchel, W.
    Meininger, G.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (04): : 372 - 382
  • [2] Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis
    Sinclair, Alan J.
    Bode, Bruce
    Harris, Stewart
    Vijapurkar, Ujjwala
    Shaw, Wayne
    Desai, Mehul
    Meininger, Gary
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (03) : 543 - 552
  • [3] Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus and chronic kidney disease over 52 weeks
    Nieto, J.
    Yale, J. -F.
    Bakris, G.
    Cariou, B.
    Wajs, E.
    Figueroa, K.
    Jiang, J.
    Usiskin, K.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 : S381 - S381
  • [4] EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM INDIA
    Kumar, K. M. Prasanna
    Mohan, V.
    Sethi, B.
    Gandhi, P.
    Bantwal, G.
    Xie, J.
    Meininger, G.
    Qiu, R.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S260 - S261
  • [5] Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
    Yale, J-F
    Bakris, G.
    Cariou, B.
    Yue, D.
    David-Neto, E.
    Xi, L.
    Figueroa, K.
    Wajs, E.
    Usiskin, K.
    Meininger, G.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 463 - 473
  • [6] Safety assessment of canagliflozin for type 2 diabetes mellitus
    Fan, Guoxin
    Han, Ruoshuang
    Zhang, Yuxin
    Zhang, Zhiyin
    Liu, Yifan
    Wang, Dongdong
    He, Shisheng
    Chen, Zhengqi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2595 - 2612
  • [7] Efficacy and safety of canagliflozin (CANA), a sodium glucose co-transporter 2 inhibitor (SGLT2), in older subjects with type 2 diabetes mellitus
    Bode, B.
    Stenlof, K.
    Sullivan, D.
    Fung, A.
    Usiskin, K.
    Meininger, G.
    [J]. DIABETOLOGIA, 2012, 55 : S315 - S315
  • [8] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America
    Lavalle-Gonzalez, Fernando J.
    Eliaschewitz, Freddy G.
    Cerdas, Sonia
    Del Pilar Chacon, Maria
    Tong, Cindy
    Alba, Maria
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (03) : 427 - 439
  • [9] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
    John, M.
    Violante, R.
    Deerochanawong, C.
    Vijapurkar, U.
    Canovatchel, W.
    Hamilton, G.
    [J]. DIABETOLOGIA, 2015, 58 : S363 - S363
  • [10] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
    John, Mathew
    Cerdas, Sonia
    Violante, Rafael
    Deerochanawong, Chaicharn
    Hassanein, Mohamed
    Slee, April
    Canovatchel, William
    Hamilton, Gill
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (09) : 775 - 785
12345